27 Jul Invetech
David Hodl, Head of Business Development for Cell Therapy
Melbourne, Australia
(ASX: FTV)
Virtual Presentation
Invetech helps cell and gene therapy developers to visualize, strategize, and manage the future. With proven processes, expert insights, and full-spectrum services, we swiftly accelerate life-changing therapies from clinical to commercial-scale manufacturing. With configurable technology platforms and automated production systems, we enable predictable, reproducible products of the highest quality and efficacy. Our integrated approach brings together biological scientists, engineers, designers, and program managers to deliver successful market offerings to more people globally. Working in close collaboration with early-stage and mature life science companies, we are committed to advancing the next generation of vital, emerging therapies to revolutionize healthcare and precision medicine.
